Sangamo Therapeutics
SGMO
#10572
Rank
โ‚น2.86 B
Marketcap
โ‚น6.92
Share price
0.00%
Change (1 day)
-80.97%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚น9.92 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น34.55 Million. In 2025 the company made an earning of -โ‚น10.1 Billion a decrease over its 2024 earnings that were of -โ‚น9.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.92 Billion-1.77%
2025 -โ‚น10.1 Billion9.71%
2024 -โ‚น9.21 Billion-17.27%
2023 -โ‚น11.13 Billion-40.88%
2022 -โ‚น18.82 Billion9.79%
2021 -โ‚น17.14 Billion41.52%
2020 -โ‚น12.11 Billion23.17%
2019 -โ‚น9.84 Billion36.33%
2018 -โ‚น7.22 Billion36.89%
2017 -โ‚น5.27 Billion-22.32%
2016 -โ‚น6.79 Billion54.86%
2015 -โ‚น4.38 Billion75.62%
2014 -โ‚น2.5 Billion0.13%
2013 -โ‚น2.5 Billion
2011 -โ‚น3.35 Billion43.66%
2010 -โ‚น2.34 Billion28.52%
2009 -โ‚น1.82 Billion-23.55%
2008 -โ‚น2.38 Billion2.45%
2007 -โ‚น2.32 Billion19.5%
2006 -โ‚น1.94 Billion50.78%
2005 -โ‚น1.29 Billion75%
2004 -โ‚น0.74 Billion-33.25%
2003 -โ‚น1.11 Billion-62.27%
2002 -โ‚น2.92 Billion102.82%
2001 -โ‚น1.44 Billion23.21%
2000 -โ‚น1.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.749 T-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.033 T-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.60 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น39.73 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น236.76 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น628.39 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น114.16 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.08 B-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA